Abstract
We report preliminary results from a multi-center trial of evaluating the performance of a novel, full-field multispectral tissue fluorescence imaging system (Cerviscan™) designed to detect cervical squamous intraepithelial lesions. Spectral data from multiple regions of 48 patients enrolled from clinical performance sites in the US and Canada are included in this preliminary analysis. This includes 30 women used for the training set and 18 use for the testing set. In the testing set, 37/43 SIL and 70/80 NonSIL regions were correctly identified for a sensitivity of 86% and specificity of 87.5%. Cerviscan™ locates cervical precancerous lesions with high sensitivity and specificity and has the potential to permit ‘see and treat’ patient management.
© 2001 OSA/SPIE
PDF ArticleMore Like This
Irene Georgakoudi, Ellen E. Sheets, Christopher P. Crum, Markus G. Mueller, Vadim Backman, and Michael S. Feld
4432_1 European Conference on Biomedical Optics (ECBO) 2001
Michele Follen, Sylvia F. Lam, Martial Guillaud, Deanna Ceron, Jessica McAlpine, Tom Ehlen, Dianne Miller, Dennis D. Cox, E. Neely Atkinson, Roderick Price, Dirk van Niekerk, Timon P. H. Buys, Pierre M. Lane, and Calum E. MacAulay
BTu3A.25 Biomedical Optics (BIOMED) 2012
Aleksander Sieron, Mariusz Adamek, Tomasz Biniszkiewicz, Wojciech Cebula, Grzegorz Cieslar, Aleksandra Kawczyk - Krupka, Grzegorz Niepsuj, Michał Szygula, Boguslaw Wojciechowski, and Witold Zieleznik
4433_120 European Conference on Biomedical Optics (ECBO) 2001